DSCPX
Price
$17.57
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
FSSNX
Price
$28.08
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

DSCPX vs FSSNX

Header iconDSCPX vs FSSNX Comparison
Open Charts DSCPX vs FSSNXBanner chart's image
Davenport Small Cap Focus
Price$17.57
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Fidelity Small Cap Index
Price$28.08
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DSCPX vs FSSNX Comparison Chart
Loading...
VS
DSCPX vs. FSSNX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSCPX is a Buy and FSSNX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 27.3B vs. DSCPX (974M). FSSNX pays higher dividends than DSCPX: FSSNX (1.36) vs DSCPX (0.58). DSCPX was incepted earlier than FSSNX: DSCPX (10 years) vs FSSNX (13 years). DSCPX is a more actively managed with annual turnover of: 36.00 vs. FSSNX (9.00). FSSNX has a lower initial minimum investment than DSCPX: FSSNX (0) vs DSCPX (5000). FSSNX annual gain was more profitable for investors over the last year : 22.65 vs. DSCPX (7.70). FSSNX return over 5 years is better than : 44.62 vs. DSCPX (26.98).
DSCPXFSSNXDSCPX / FSSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years13 years-
Gain YTD-0.4269.972-4%
Front LoadN/AN/A-
Min. Initial Investment50000-
Min. Initial Investment IRAN/AN/A-
Net Assets974M27.3B4%
Annual Yield % from dividends0.581.3643%
Returns for 1 year7.7022.6534%
Returns for 3 years-8.590.65-1,322%
Returns for 5 years26.9844.6260%
Returns for 10 yearsN/A84.24-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD3.490.05
+1.45%
Relmada Therapeutics
BSAC20.240.18
+0.90%
Banco Santander-Chile
ODC67.85-0.79
-1.15%
Oil-Dri Corp
HRMY38.34-0.47
-1.21%
Harmony Biosciences Holdings
THAR2.94-0.05
-1.67%
Tharimmune Inc.